Inspire Medical Systems, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of Class II Directors: Dana G. Mead, Jr.

Inspire Medical Systems, Inc.’s own tally for this item (“Elect Director: Dana G. Mead, Jr.”): 21,950,770 for, 1,200,972 withheld, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors 2 The following director nominees were elected as Class II directors to hold office until the Company's annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified.”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 10,383,212 for, 216,728 withheld, 709 abstained.

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

Description as filed by funds: Election of Class II Directors: Gary L. Ellis

Inspire Medical Systems, Inc.’s own tally for this item (“Elect Director: Gary L. Ellis”): 17,268,398 for, 5,883,344 withheld, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors 2 The following director nominees were elected as Class II directors to hold office until the Company's annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified.”
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 9,105,767 for, 1,405,757 withheld, 89,126 abstained.

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

Description as filed by funds: Election of Class II Directors: Georgia Melenikiotou

Inspire Medical Systems, Inc.’s own tally for this item (“Elect Director: Georgia Melenikiotou”): 22,693,412 for, 458,330 withheld, per its Form 8-K filed May 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors 2 The following director nominees were elected as Class II directors to hold office until the Company's annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 10,592,886 for, 7,761 withheld, 2 abstained.

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

Description as filed by funds: APPROVAL OF AN AMENDMENT TO THE COMPANY'S SEVENTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO PHASE OUT THE CLASSIFIED BOARD STRUCTURE AND PROVIDE FOR THE ANNUAL ELECTION OF ALL DIRECTORS BEGINNING WITH THE COMPANY'S 2029 ANNUAL MEETING OF STOCKHOLDERS.

Inspire Medical Systems, Inc.’s own tally for this item (“5. Approval of an Amendment to the Company's Certificate of Incorporation to Phase Out the Classified Board Structure and Provide for the Annual Election of All Directors Beginning with the Company's 2029 Annual Meeting ”): 23,121,710 for, 11,103 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5 — Approval of an Amendment to the Company's Certificate of Incorporation to Phase Out the Classified Board Structure and Provide for the Annual Election of All Directors Beginning with the Company's 2029 Annual Meeting of Stockholders The Company's stockholders approved the amendment to …”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 10,594,726 for.

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

Description as filed by funds: APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES AT THE TIME OF THE ANNUAL MEETING TO APPROVE PROPOSAL NO. 5 AND/OR PROPOSAL NO. 6.

Inspire Medical Systems, Inc.’s own tally for this item (“7. Approval of an Adjournment of the Annual Meeting, if necessary, to Solicit Additional Proxies if there are Not Sufficient Votes at the Time of the Annual Meeting to Approve Proposal No. 5 and/or Proposal No. 6”): 21,795,417 for, 1,281,054 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 7: Approval of an Adjournment of the Annual Meeting, if necessary, to Solicit Additional Proxies if there are Not Sufficient Votes at the Time of the Annual Meeting to Approve Proposal No. 5 and/or Proposal No. 6 The Company's stockholders approved the adjournment of the”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 88 asset managers below reported 9,928,323 for, 649,735 against, 3,368 abstained.

Showing the 25 largest of 88 asset managers. See all 88 in the interactive database.

Description as filed by funds: APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE INSPIRE MEDICAL SYSTEMS, INC. 2018 INCENTIVE AWARD PLAN.

Inspire Medical Systems, Inc.’s own tally for this item (“6. Approval of an Amendment and Restatement of the Inspire Medical Systems, Inc”): 14,330,536 for, 8,796,686 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 6 — Approval of an Amendment and Restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan 3 The Company's stockholders approved the amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan:”
Support: 62% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 92 asset managers below reported 8,505,100 for, 2,097,727 against, 4,868 abstained.

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

Description as filed by funds: Approval, on an advisory (non- binding) basis, of the compensation of the Company's named executive officers.

Inspire Medical Systems, Inc.’s own tally for this item (“3. Approval, on an Advisory (Non-Binding) Basis, of the Compensation of the Company's Named Executive Officers”): 22,508,636 for, 595,867 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 — Approval, on an Advisory (Non-Binding) Basis, of the Compensation of the Company's Named Executive Officers The Company's stockholders approved, on an advisory (non-binding) basis, the compensation of the Company's named executive officers by voting as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 88 managers: 10,585,993 for, 11,133 against, 17,368 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 284 managers: 15,233,575 for, 452,176 against, 13,518 abstained, 11,929 not voted, 39,470 1 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Approval, on an advisory (non- binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 39 managers: 3,368 abstained, 4,563,534 1 year, 20,926 unknown, 9,299 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 140 managers: 23,682 for, 11,929 not voted, 6,839,289 1 year, 4,555 3 year, 55 unknown, 50 2 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 55 managers: 13,954 for, 5,943,637 1 year, 39,853 3 year. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 134 managers: 34,490 for, 8,760,108 1 year, 45,678 3 year. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.

Inspire Medical Systems, Inc.’s own tally for this item (“2. Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the year ending December 31, 2026”): 25,089,422 for, 170,682 against — passed, per its Form 8-K filed May 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 — Ratification of the Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the year ending December 31, 2026 The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting f…”
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 89 asset managers below reported 10,600,208 for, 11,073 against, 3,368 abstained.

Showing the 25 largest of 89 asset managers. See all 89 in the interactive database.